Gilead Sciences funds nonprofit-led, innovative projects that strengthen healthcare infrastructure and education in HIV, liver disease, oncology, and chronic inflammatory diseases worldwide.
Funder: Gilead Sciences
Due Dates: Rolling (applications accepted year-round; submit at least 6 weeks before project start)
Funding Amounts: No set minimum or maximum; funding is project-specific and typically for up to one year.
Summary: Supports nonprofit-led, innovative, and high-impact projects that strengthen healthcare infrastructure and education in HIV, liver disease, oncology, and chronic inflammatory diseases globally.
Key Information: Only nonprofit organizations are eligible; retroactive funding is not allowed; applications must be submitted at least 6 weeks before the activity.
Gilead Sciences' grant funding program provides support for community-informed, data-driven projects that aim to strengthen healthcare infrastructures, deliver education, and provide financial assistance to vulnerable populations worldwide. The focus is on projects related to HIV (including cure and prevention), liver diseases (such as hepatitis B, C, D, and primary biliary cholangitis), oncology (hematology and solid tumors), and chronic inflammatory or respiratory diseases. Gilead prioritizes proposals with clear, measurable outcomes and encourages innovative approaches addressing unmet needs in healthcare delivery, education, and access.